Powder: -20°C for 3 years | In solvent: -80°C for 1 year
AG126 (Tyrphostin AG126) selectively inhibits the phosphorylation of ERK1 (p44) and ERK2 (p42) at 25-50 μM. It blocks the production of TNF-α in vitro2 and in vivo, attenuating signaling through NF-κB, the induced expression of COX-2 and iNOS, and the inflammatory response in diverse animal models. AG-126 weakly inhibits epidermal GFRK (IC50: 450 μM) and platelet-derived GFRK (IC50 < 100 μM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 30.00 | |
2 mg | In stock | $ 43.00 | |
5 mg | In stock | $ 67.00 | |
10 mg | In stock | $ 117.00 | |
25 mg | In stock | $ 233.00 | |
50 mg | In stock | $ 346.00 | |
100 mg | In stock | $ 513.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 71.00 |
Description | AG126 (Tyrphostin AG126) selectively inhibits the phosphorylation of ERK1 (p44) and ERK2 (p42) at 25-50 μM. It blocks the production of TNF-α in vitro2 and in vivo, attenuating signaling through NF-κB, the induced expression of COX-2 and iNOS, and the inflammatory response in diverse animal models. AG-126 weakly inhibits epidermal GFRK (IC50: 450 μM) and platelet-derived GFRK (IC50 > 100 μM). |
Targets&IC50 | GFRK:> 100 μM, GFRK:450 μM, ERK2 (p42):25-50 μM, ERK1 (p44):25-50 μM |
Synonyms | Tyrphostin AG126, AG 126 |
Molecular Weight | 215.16 |
Formula | C10H5N3O3 |
CAS No. | 118409-62-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 100 mg/mL (464.75 mM), Sonication and heating are recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
AG126 118409-62-4 Immunology/Inflammation MAPK Neuroscience ERK COX Tyrphostin AG-126 Extracellular signal regulated kinases Tyrphostin AG 126 BRMECs Inhibitor inhibit AG-126 Tyrphostin AG126 ARPE-19 AG 126 inhibitor